InvestorsHub Logo
Followers 0
Posts 20
Boards Moderated 0
Alias Born 07/31/2007

Re: opportunityknocking post# 25846

Wednesday, 02/24/2010 3:31:14 PM

Wednesday, February 24, 2010 3:31:14 PM

Post# of 30387
The pairing of Recaf with the other markers was mentioned by Burger in the call as something they would be pursuing, as I remember the call. Can anyone confirm that?

Since the results of BioCurex's combo tests were presented in September at an internatioonal oncology conference in Europe just prior to Burger's commitment (publicly) to proceed in a big way with this new effort, I've got to believe those results are for real - although unpublished.

I appreciate Goldie's skepticism as a learning tool for me (and other new investors). He also serves to elicit info from other long-time holders who disagree with him. Which is even more helpful!

Having now heard both sides, and knowing well Dr. Burger's successful many many year long sheparding of antisense genetic manipulation technology with AVI Biopharma (now finally showing what it can do in muscular dystrphy), I'm fairly confident he wouldn't be wasting his time at his age on some fly-by-night shot in the dark.He's got to be pretty confident this effort is going to pay off. He's just been around too long to bother with something like this unless he's amost gauranteed it's going to succeed.

Then again, he perhaps had a Freudian slip at the outset of his call where he said "experiment" instead of "enthusiasm" (and corrected himself)!!! So yes, he could see this as a two year experiment - that if it works will be fantastic, but if it doesn't at least they tried.

I can imagine him doing it if he saw it having at least a 75% chance of working out. Anything less than that I don't see him bothering with. I'll take those odds too.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.